ByHeart, Inc.

Healthtech New York, NY

About

Issuer

Entity type
Corporation
Jurisdiction
Delaware
Sector
Healthtech
Headquarters
New York, NY
Street
131 Varick Street
Zip
10013

Offering

Total offering
$173.1M
Amount sold
$72.2M
First sale
Mar 12, 2025
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
49

How this filing compares

Ranked #1 of 23 Healthtech filings in March 2026 by offering amount.

Median Healthtech filing in March 2026: $1M. This offering is 173.1× the median.

Other New York filings this week: AM-0316 Fund I, a series of Nebular Expansion, LP, Ascendancy Fund, LP, Bayberry Onshore Fund LP, CanAm PIDC Regional Center, LP XXXVIII, COMMUNITY DEVELOPMENT TRUST INC

Leadership

Ron Belldegrun — Executive Officer (also: Director)

Georg Krause-Vilmar — Executive Officer

Mia B. Funt — Executive Officer (also: Director)

Devon Kuehn — Executive Officer

Niall Mullane — Executive Officer

Arie Belldegrun — Director

Joshua Bradley — Director

Joshua Kazam — Director

Anton Linderum — Director

Guy Oranim — Director

Amy Schulman — Director

Tommy Burke — Director

Hemi Zucker — Director

Denice Torres — Director

Elizabeth Abrams — Director

Raphael Wallander — Director

Filing details

ByHeart, Inc. filed a Form D with the SEC on March 31, 2026.

Other newest Healthtech companies

Other newest companies in New York